Prescription Required
Formulation: Powder Inhalation
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Powder Inhalation
Select the quantity to see the price.
We don't charge dispensing fee
Shipped and delivered directly to your doorstep
Incruse Ellipta (active ingredient: umeclidinium) is a prescription medication indicated for:
Incruse Ellipta belongs to a class of drugs known as long-acting muscarinic antagonists (LAMA), which work by blocking the action of acetylcholine at muscarinic receptors in the airways, leading to bronchodilation and improved airflow in the lungs, thereby helping to alleviate symptoms of COPD.
Incruse Ellipta halation powder is taken by mouth using an inhaler, once daily as directed by your doctor. Do not open the cover of the inhaler until you are ready to use it, since doing so prepares a dose of the medication. In case you open and close the inhaler without inhaling, the dose will be lost. Therefore, to avoid wasting a dose, inhale the medication immediately after opening the cover and do not close it until after inhaling. While inhaling, it is possible to taste or feel the drug, but do not exhale into the inhaler.
Incruse Ellipta (Umeclidinium Bromide) is available in the following forms and strengths:
To use Incruse Ellipta, you breathe it into your lungs through your mouth using the inhaler. Follow the instructions provided by your healthcare provider.
Incruse Ellipta is not intended to provide immediate relief, but with regular use, you should expect to breathe easier over time.
Talk to your doctor before taking Incruse Ellipta if you are pregnant, planning to become pregnant, or breastfeeding.
Tell your doctor about all the medicines you are taking, including over-the-counter medicines and supplements, before using Incruse Ellipta.
Follow the instructions provided by your healthcare provider. Typically, Incruse Ellipta is used once daily.
Do not stop using Incruse Ellipta as prescribed, even if your symptoms improve. Stopping the medicine without your doctor’s guidance may worsen your condition.
| Generic name: | Umeclidinium Bromide |
|---|---|
| Formulation: | Powder Inhalation |
| Strength(s): | 62.5mcg |
| Quantities Available: | 90doses |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Incruse Ellipta (umeclidinium) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Incruse Ellipta is available in 30, 60, or 90 doses of powder inhalation with 62.5 mcg strength and is typically prescribed as one inhalation once daily. For a 90-day supply, you would order either one inhaler with 90 doses, two inhalers with 60 doses each, or three inhalers with 30 doses each, depending on availability and your preference.
No, we don’t sell umeclidinium. However, you can still enjoy low prices on Incruse Ellipta, which contains umeclidinium as an active ingredient. To order, you’ll need a valid prescription from your healthcare provider, as we require this to dispense the medication safely and accurately. You can conveniently submit your prescription by mail, fax, or by uploading it through your online account during the ordering process.
Yes, we ship Incruse Ellipta (umeclidinium) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Incruse Ellipta (Umeclidinium Bromide). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Incruse Ellipta (Umeclidinium Bromide).
REVIEWS